Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schulz

Showing results (411-420 of 906) with videos related to

Pageof 91
Sort By:
Journal of Neurochemistry|August 29, 2018
Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factorDaniel Komnig, Toruntay Cem Dagli, Pardes Habib, et al.
Fortschritte Der Neurologie-Psychiatrie|March 3, 2010
[On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease]J Kassubek, T Büttner, H Reichmann, et al.
Molecular and Cellular Neurosciences|February 13, 2001
Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectorsS Kügler, L Meyn, H Holzmüller, et al.
IEEE Transactions on Medical Imaging|November 13, 2009
Hybrid system for simultaneous fluorescence and x-ray computed tomographyRalf B Schulz, Angelique Ale, Athanasios Sarantopoulos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cellsU Wüllner, M Weller, J Kornhuber, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2001
Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's diseaseX G Xia, T Harding, M Weller, et al.
Diabetes Care|March 1, 1983
Reproducibility of insulin dosage on consecutive days of blood glucose control by an artificial beta-cell in brittle diabetic patientsW Bruns, H Bombor, E Jutzi, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|June 15, 2022
Effect of strength training on orthostatic hypotension in Parkinson's disease-a pilot studySvenja Hüsch, Joana Schauermann, Bruno Fimm, et al.
International Journal of Clinical Pharmacy|October 30, 2015
Analysis of drug-related problems in three departments of a German University hospitalRebekka Lenssen, Axel Heidenreich, Jörg B Schulz, et al.
Cell Death & Disease|September 9, 2016
Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse modelAnja Drinkut, Karsten Tillack, Durga P Meka, et al.
Pageof 91

Showing results (411-420 of 906) with videos related to

Sort By:
Pageof 91
Journal of Neurochemistry|August 29, 2018
Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factorDaniel Komnig, Toruntay Cem Dagli, Pardes Habib, et al.
Fortschritte Der Neurologie-Psychiatrie|March 3, 2010
[On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease]J Kassubek, T Büttner, H Reichmann, et al.
Molecular and Cellular Neurosciences|February 13, 2001
Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectorsS Kügler, L Meyn, H Holzmüller, et al.
IEEE Transactions on Medical Imaging|November 13, 2009
Hybrid system for simultaneous fluorescence and x-ray computed tomographyRalf B Schulz, Angelique Ale, Athanasios Sarantopoulos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cellsU Wüllner, M Weller, J Kornhuber, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2001
Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's diseaseX G Xia, T Harding, M Weller, et al.
Diabetes Care|March 1, 1983
Reproducibility of insulin dosage on consecutive days of blood glucose control by an artificial beta-cell in brittle diabetic patientsW Bruns, H Bombor, E Jutzi, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|June 15, 2022
Effect of strength training on orthostatic hypotension in Parkinson's disease-a pilot studySvenja Hüsch, Joana Schauermann, Bruno Fimm, et al.
International Journal of Clinical Pharmacy|October 30, 2015
Analysis of drug-related problems in three departments of a German University hospitalRebekka Lenssen, Axel Heidenreich, Jörg B Schulz, et al.
Cell Death & Disease|September 9, 2016
Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse modelAnja Drinkut, Karsten Tillack, Durga P Meka, et al.
Pageof 91